4/13/2023 0 Comments Atc3 forum international![]() At the same time, the Netherlands Authority for Consumers & Markets acknowledges that it will keep an eye on maintaining incentives for innovation.Īs part of the announcement of the key priorities, the Netherlands Authority for Consumers & Markets has called on all interested parties to share their thoughts and ideas about the key priorities. ![]() The Netherlands Authority for Consumers & Markets stressed in their announcement that competition in the pharmaceutical industry stimulates innovation and will maintain affordability of prescription medicinal products. When looking into pharmaceutical pricing, the Netherlands Authority for Consumers & markets will cooperate with competition authorities in other countries and with the Dutch Healthcare Authority (NZa). One of the four key priorities is the pricing of prescription medicinal products. On 13 February 2018, the Dutch Competition Authority (Netherlands Authority for Consumers & Markets, ACM) announced its four key priorities for 2018-2019. Pricing of medicinal products continues to be a hot topic in the Netherlands, not only in political debate or from a regulatory and reimbursement perspective, but also from a competition law perspective. Hogan Lovells Publications | 16 February 2018 Pharmaceutical pricing key priority for Dutch Competition Authority in 2018-2019
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |